IP Library Granted Patent US 11,808,768
Granted Patent B2
US 11,808,768 · App. 17/099,290 · Granted Nov 7, 2023

1,1 ′-[[(substituted alkyl)imino]bis (alkylene)]bis- ferrocenes and their use in I electrochemical assays by labelling substrates of interest

Inventors: Barrie Marsh (Trowbridge, GB); Christopher Frost (Bath And Northeast Somerset, GB); David Pearce (Trowbridge, GB)
Assignee: Binx Health Limited
G01N33/58C07F17/02C12Q1/6816
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,808,768
App. No.
17/099,290
Granted
Nov 7, 2023
Kind
B2
Abstract

Compounds of general formula I wherein Fc and Fc′ may be the same or different and are substituted ferrocenyl moieties having at least one ring substituent selected from sulfur-containing groups, phosphorus-containing groups, iodo, chloro, silyl, fluoroalkyl groups containing two or more fluorine atoms, heteroaryl, substituted phenyl, and cyano, wherein if present as sole substituent the cyano group is located on the proximal cyclopentadienyl ring; X is a spacer, Y is a spacer, Z is a spacer; and R is a linker group. Compound I may be used to make labelled substrates, functionalised compounds for making labelled substrates and may be used as labels in an electrochemical assay.

Claims (19)

1. A method of detecting a nucleic acid, the method comprising:

contacting the nucleic acid with a complementary nucleic acid probe under conditions to allow hybridization between said probe and an amplicon; and

selectively degrading the probe, wherein the probe is labelled with a compound selected from the group consisting of:

6-(bis((1′-iodoferrocenyl)1-methylferrocenyl) amino)hexan-1-ol;

6-(bis((1′-(4-nitrophenyl)ferronceyl)1-methylferrocenyl) amino) hexan-1-ol;

6-(bis((1′(1-furanyl)ferrocenyl)1-methylferrocenyl) amino)hexan-1-ol;

6-(bis((1′-chloroferrocenyl)1-methylferrocenyl) amino)hexan-1-ol; and

6-(bis((2-cyano)1-methylferrocenyl) amino)hexan-1-ol.

2. The method of claim 1 , wherein the probe is labelled with the compound 6-(bis((1′-iodoferrocenyl)1-methylferrocenyl) amino)hexan-1-ol.

3. The method of claim 1 , wherein the probe is labelled with the compound 6-(bis((1′-(4-nitrophenyl)ferronceyl)1-methylferrocenyl) amino) hexan-1-ol.

4. The method of claim 1 , wherein the probe is labelled with the compound 6-(bis((1′(1-furanyl)ferrocenyl)1-methylferrocenyl) amino) hexan-1-ol.

5. The method of claim 1 , wherein the probe is labelled with the compound 6-(bis((1′-chloroferrocenyl)1-methylferrocenyl) amino)hexan-1-ol.

6. The method of claim 1 , wherein the probe is labelled with the compound 6-(bis((2-cyano)1-methylferrocenyl) amino)hexan-1-ol.

7. The method of claim 1 , further comprising measuring electrochemical activity of the compound labelling the probe, wherein said electrochemical activity is dependent either quantitatively or qualitatively on the degradation of the probe.

8. The method of claim 2 , further comprising measuring electrochemical activity of the compound labelling the probe, wherein said electrochemical activity is dependent either quantitatively or qualitatively on the degradation of the probe.

9. The method of claim 3 , further comprising measuring electrochemical activity of the compound labelling the probe, wherein said electrochemical activity is dependent either quantitatively or qualitatively on the degradation of the probe.

10. The method of claim 4 , further comprising measuring electrochemical activity of the compound labelling the probe, wherein said electrochemical activity is dependent either quantitatively or qualitatively on the degradation of the probe.

11. The method of claim 5 , further comprising measuring electrochemical activity of the compound labelling the probe, wherein said electrochemical activity is dependent either quantitatively or qualitatively on the degradation of the probe.

12. The method of claim 6 , further comprising measuring electrochemical activity of the compound labelling the probe, wherein said electrochemical activity is dependent either quantitatively or qualitatively on the degradation of the probe.

Assignments (6)
SECURITY INTEREST Recorded Mar 25, 2025
From: BINX HEALTH LIMITED
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 070620/0287 →
RELEASE OF SECURITY INTEREST Recorded Jan 18, 2025
From: BX HEP AGGREGATOR, LLC,
To: BINX HEALTH LIMITED
Reel/Frame 069925/0466 →
ASSIGNMENT OF PATENT SECURITY AGREEMENT Recorded Oct 3, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: BX HEP AGGREGATOR, LLC
Reel/Frame 069107/0116 →
PATENT SECURITY AGREEMENT Recorded Apr 7, 2021
From: BINX HEALTH LIMITED
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 055859/0724 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2021
From: MARSH, BARRIE; FROST, CHRISTOPHER; PEARCE, DAVID
To: ATLAS GENETICS LIMITED
Reel/Frame 054969/0409 →
CHANGE OF NAME Recorded Jan 20, 2021
From: ATLAS GENETICS LIMITED
To: BINX HEALTH LIMITED
Reel/Frame 054969/0496 →
Priority Claims (1)
GB 1211157 · Jun 22, 2012 · national
Continuity (4)
Division 16664306 · Oct 25, 2019
Continuation 15906241 · Feb 27, 2018
Continuation 14410296
Related Publication 20210116457A1 · Apr 22, 2021
Cited By (1)
US 12,601,703